Page last updated: 2024-08-21

thiazoles and almorexant

thiazoles has been researched along with almorexant in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borroni, E; Knoflach, F; Malherbe, P; Pinard, E; Wettstein, JG1
Bissantz, C; Kratzeisen, C; Malherbe, P; Marcuz, A; Roche, O; Wettstein, JG1
Antolini, M; Corsi, M; di Fabio, R; Faedo, S; Merlo Pich, E; Perdonà, E1
Czajkowska, B; Krzystanek, M; Lapray, D; Markowski, G; Pałasz, A; Peyron, C; Rojczyk-Gołębiewska, E; Skowronek, R; Wiaderkiewicz, R1
Hoyer, D; Jacobson, LH1

Reviews

2 review(s) available for thiazoles and almorexant

ArticleYear
Dual orexin receptor antagonists - promising agents in the treatment of sleep disorders.
    The international journal of neuropsychopharmacology, 2014, Volume: 17, Issue:1

    Topics: Acetamides; Animals; Azepines; Benzofurans; Humans; Isoquinolines; Models, Biological; Orexin Receptor Antagonists; Orexin Receptors; Piperidines; Pyrimidines; Sleep; Sleep Initiation and Maintenance Disorders; Thiazoles; Triazoles; Wakefulness

2014
Orexin in sleep, addiction and more: is the perfect insomnia drug at hand?
    Neuropeptides, 2013, Volume: 47, Issue:6

    Topics: Acetamides; Animals; Azepines; Behavior, Addictive; Benzofurans; Feeding Behavior; Humans; Intracellular Signaling Peptides and Proteins; Isoquinolines; Mice; Neuropeptides; Orexin Receptor Antagonists; Orexin Receptors; Orexins; Piperidines; Pyrimidines; Rats; Reward; Sleep; Sleep Initiation and Maintenance Disorders; Thiazoles; Triazoles

2013

Other Studies

3 other study(ies) available for thiazoles and almorexant

ArticleYear
Biochemical and electrophysiological characterization of almorexant, a dual orexin 1 receptor (OX1)/orexin 2 receptor (OX2) antagonist: comparison with selective OX1 and OX2 antagonists.
    Molecular pharmacology, 2009, Volume: 76, Issue:3

    Topics: Acetamides; Animals; Evoked Potentials; Humans; Isoquinolines; Kinetics; Molecular Structure; Neurons; Orexin Receptors; Phenylurea Compounds; Pyrrolidines; Rats; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Sleep; Thiazoles

2009
Mapping the binding pocket of dual antagonist almorexant to human orexin 1 and orexin 2 receptors: comparison with the selective OX1 antagonist SB-674042 and the selective OX2 antagonist N-ethyl-2-[(6-methoxy-pyridin-3-yl)-(toluene-2-sulfonyl)-amino]-N-py
    Molecular pharmacology, 2010, Volume: 78, Issue:1

    Topics: Acetamides; Amino Acid Sequence; Aminopyridines; Binding Sites; Cell Line; Humans; Isoquinolines; Molecular Sequence Data; Mutagenesis, Site-Directed; Orexin Receptors; Pyrrolidines; Radioligand Assay; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Sequence Homology, Amino Acid; Sulfonamides; Thiazoles

2010
Functional and binding kinetic studies make a distinction between OX1 and OX2 orexin receptor antagonists.
    European journal of pharmacology, 2012, Oct-05, Volume: 692, Issue:1-3

    Topics: Acetamides; Animals; Benzofurans; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Dioxanes; Humans; Isoquinolines; Kinetics; Orexin Receptors; Phenylurea Compounds; Piperidines; Protein Binding; Pyrimidines; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Thiazoles

2012